Stem Cell Innovations Cites Two Recent Government Documents Supporting The Use Of Cell-Based Assays For Toxicity Testing
Stem Cell Innovations (SCLL.OB) (SCI) noted that two recent government panels, one in the US and one in the UK, advocate the use of cell-based assays for toxicity testing. The Company’s human liver-based ACTIVTox® and stem cell-based PluriCell? systems are specifically designed for this purpose. [click link for full article]
More: continued here
Filed under: Stem Cell Research on October 25th, 2007